FRESHKOTE LUBRICANT EYEDROPS, 10mL recall — Harrow Eye LLC (Class II)
Harrow Eye LLC is recorded by the U.S. Food and Drug Administration (FDA) as recalling FRESHKOTE LUBRICANT EYEDROPS, 10mL — a Class II recall, initiated 2026-04-17 and posted to the FDA enforcement report on 2026-04-29, under recall number D-0489-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “Lack of Assurance of Sterility”. From the product description, the strength given is 10mL and the package is described as 0.33 FL OZ (10mL). Distribution is recorded as “Nationwide within the United States” — Nationwide (US), with the recalling firm on record in TN, United States. It is the only recall number the FDA has filed under event ID 98766. 12 days separate the firm's initiation date from the FDA's report date on this record. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.
Regulatory snapshot
| Recall number | D-0489-2026 |
|---|---|
| FDA event ID | 98766 |
| Classification | Class II (intermediate regulatory tier) |
| Status | Ongoing |
| Recalling firm | Harrow Eye LLC |
| Recall initiated | 2026-04-17 |
| Reported by FDA | 2026-04-29 |
| Report lag | 12 days from initiation to report |
| Distribution | Nationwide within the United States — Nationwide (US) |
| Firm location on record | TN, United States |
| Product description (source) | FRESHKOTE LUBRICANT EYEDROPS, Sterile, 0.33 FL OZ (10mL), Harrow Eye LLC, Nashville, TN USA. |
Reason reported by FDA
Lack of Assurance of Sterility
5 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.
Product identifiers in this record
2 identifying values matched by exact pattern in the 14-word product description above; each is a literal substring of it.
| Product named | FRESHKOTE LUBRICANT EYEDROPS |
|---|---|
| Strength | 10mL |
| Package | 0.33 FL OZ (10mL) |
Reported in the same month (2026-04)
6 enforcement reports carry a report date in 2026-04; these 4 are the Class II ones nearest this record.
| Recall record | Recall number | Recalling firm | FDA tier | Reported |
|---|---|---|---|---|
| Furosemide Tablets, 80 mg | D-0486-2026 | Leading Pharma, LLC | Class II | 2026-04-29 |
| Omega-3-Acid, 1 gram | D-0493-2026 | The Harvard Drug Group LLC | Class II | 2026-04-29 |
| DEXTROSE INJECTION USP, 70% | D-0496-2026 | B Braun Medical Inc | Class II | 2026-04-29 |
| LACTATED RINGER'S IRRIGATION, 3000 mL | D-0498-2026 | B Braun Medical Inc | Class II | 2026-04-29 |
Nearest Class II recalls by date
213 of 250 indexed records share the Class II tier; the 10 nearest to 2026-04-29 by report date are listed here.
| Recall record | Recall number | Recalling firm | Strength / form | Reported |
|---|---|---|---|---|
| Systane, 10g | D-0491-2026 | Alcon Research LLC | 10g · Gel | 2026-05-06 |
| GenTeal Tears, 10g | D-0492-2026 | Alcon Research LLC | 10g · Gel | 2026-05-06 |
| Optase Dry Eye Intense Drops (Glycerin 0.2%) | D-0499-2026 | Scope Health | 0.2% · Drops | 2026-05-06 |
| iVIZIA, 0.5% | D-0500-2026 | Thea Pharma, Inc. | 0.5% · Eye Drops | 2026-05-06 |
| Similasan, 0.5% | D-0501-2026 | Thea Pharma, Inc. | 0.5% · Eye Drops | 2026-05-06 |
| Phenylephrine Hydrochloride Injectable Solution, 40mg | D-0502-2026 | Wells Pharma OF Houston LLC | 40mg · Solution | 2026-05-06 |
| fentaNYL Citrate Injectable Solution, 1000 mcg/100 mL | D-0503-2026 | Wells Pharma OF Houston LLC | 1000 mcg/100 mL · Solution | 2026-05-06 |
| fentaNYL Citrate injectable Solution in 0.9% Sodium Chloride | D-0504-2026 | Wells Pharma OF Houston LLC | 0.9% · Solution | 2026-05-06 |
| fentaNYL Citrate Injectable Solution, 1250 mcg/25mL | D-0505-2026 | Wells Pharma OF Houston LLC | 1250 mcg/25mL · Solution | 2026-05-06 |
| fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride | D-0506-2026 | Wells Pharma OF Houston LLC | 0.9% · Solution | 2026-05-06 |
Reading this record
Class II is the FDA's own severity tier for the recall action — 213 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual.
Namespace context: the Class II index (213 records) and the recall hub (250 records, 118 FDA events); Harrow Eye LLC (1 indexed records) aggregates this firm across datasets.
Coverage and limits of this record
This page reflects the openFDA enforcement report for D-0489-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.
Source & provenance
- Official source
- https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0489-2026%22
- Source dataset
- openFDA Drug Enforcement API
- Publication date
- 2026-04-29
- Ingested
- 2026-08-22
- Record hash
721f25d8fd5795b2
Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.